{
  "hash": "e30fe1d6a3fcc2c8232d3e50858a5e2b",
  "result": {
    "engine": "knitr",
    "markdown": "---\ntitle: \"Overall Results\"\n---\n\n## Primary Meta-Analysis Results\n\nThis page presents the main findings from our Bayesian meta-analysis examining the association between blood culture time to positivity (TTP) and clinical outcomes in bacteremia.\n\n\n\n\n\n## Mortality Outcome\n\n### Summary Statistics\n\n\n::: {.cell}\n::: {.cell-output-display}\n`````{=html}\n<table class=\"table table-striped table-hover\" style=\"margin-left: auto; margin-right: auto;\">\n<caption>Summary of mortality meta-analysis results</caption>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\"> Metric </th>\n   <th style=\"text-align:right;\"> Value </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> Number of effect sizes </td>\n   <td style=\"text-align:right;\"> 20 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> Total patients </td>\n   <td style=\"text-align:right;\"> 22614 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> Frequentist pooled OR (REML) </td>\n   <td style=\"text-align:right;\"> 2.40 (1.58 - 3.63) </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> Bayesian pooled OR </td>\n   <td style=\"text-align:right;\"> 2.14 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> Bayesian 95% Credible Interval </td>\n   <td style=\"text-align:right;\"> 1.69 - 2.79 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> P(OR &gt; 1) </td>\n   <td style=\"text-align:right;\"> 100.0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> Between-study heterogeneity (τ) </td>\n   <td style=\"text-align:right;\"> 0.58 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> I² </td>\n   <td style=\"text-align:right;\"> 89.1% </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n### Key Findings\n\n::: {.callout-important}\n## Main Result\n\nShorter TTP is associated with **significantly increased mortality** with a Bayesian pooled odds ratio of **2.14** (95% CrI: 1.69–2.79).\n\nThe probability that the true OR is greater than 1 is **100%**, indicating virtual certainty of a positive association.\n:::\n\n**Clinical Interpretation:**\n\n- Patients with shorter TTP (reflecting higher bacterial inocula) have approximately **2× higher odds of mortality** compared to those with longer TTP\n- This association is consistent across diverse patient populations and pathogens\n- The finding provides strong evidence that TTP is a clinically meaningful prognostic marker in bacteremia\n\n### Comparison with Frequentist Approach\n\n\n::: {.cell}\n::: {.cell-output-display}\n`````{=html}\n<table class=\"table table-striped table-hover\" style=\"margin-left: auto; margin-right: auto;\">\n<caption>Comparison of Bayesian and frequentist meta-analysis results</caption>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\"> Approach </th>\n   <th style=\"text-align:left;\"> Pooled OR (95% CI/CrI) </th>\n   <th style=\"text-align:left;\"> τ (heterogeneity) </th>\n   <th style=\"text-align:left;\"> I² (%) </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> Bayesian (brms) </td>\n   <td style=\"text-align:left;\"> 2.14 (1.69 - 2.79) </td>\n   <td style=\"text-align:left;\"> 0.58 </td>\n   <td style=\"text-align:left;\"> — </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> Frequentist (REML) </td>\n   <td style=\"text-align:left;\"> 2.40 (1.58 - 3.63) </td>\n   <td style=\"text-align:left;\"> 0.81 </td>\n   <td style=\"text-align:left;\"> 89.1% </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\nThe Bayesian and frequentist approaches yield nearly identical point estimates, providing strong validation of the robustness of our findings.\n\n### Heterogeneity\n\nThe substantial between-study heterogeneity (τ = 0.58, I² = 89.1%) suggests variability in effect sizes across studies. This heterogeneity may be attributable to:\n\n- Different TTP cutpoints used across studies\n- Variation in patient severity and comorbidity burden\n- Differences in pathogen distributions\n- Variable timing of appropriate antibiotic therapy\n- Quality of source control procedures\n\nMeta-regression analyses (see [Meta-Regression](meta_regression.qmd) page) were conducted to explore sources of heterogeneity.\n\n## Persistent Bacteremia Outcome\n\n\n\n### Summary Statistics\n\n\n::: {.cell}\n::: {.cell-output-display}\n`````{=html}\n<table class=\"table table-striped table-hover\" style=\"margin-left: auto; margin-right: auto;\">\n<caption>Summary of persistent bacteremia meta-analysis results</caption>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\"> Metric </th>\n   <th style=\"text-align:right;\"> Value </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> Number of effect sizes </td>\n   <td style=\"text-align:right;\"> 2 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> Bayesian pooled OR </td>\n   <td style=\"text-align:right;\"> 4.02 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 95% Credible Interval </td>\n   <td style=\"text-align:right;\"> 1.08 - 11.11 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> P(OR &gt; 1) </td>\n   <td style=\"text-align:right;\"> 97.9% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> Between-study heterogeneity (τ) </td>\n   <td style=\"text-align:right;\"> 1.61 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n### Key Findings\n\n::: {.callout-note}\n## Persistent Bacteremia\n\nShorter TTP is associated with **increased risk of persistent bacteremia** with a Bayesian pooled OR of **4.02** (95% CrI: 1.08–11.11).\n\nThe probability that the true OR is greater than 1 is **97.9%**.\n:::\n\nThe association between shorter TTP and persistent bacteremia is even stronger than for mortality, though based on fewer studies (k = 2). This suggests that higher bacterial inocula (reflected by shorter TTP) may predict both difficulty in achieving bacterial clearance and worse clinical outcomes.\n\n## Pathogen-Specific Analysis\n\nWe conducted stratified analyses by pathogen class to determine whether the TTP-mortality association varies between Gram-positive and Gram-negative infections.\n\n### Summary by Pathogen Class\n\n\n::: {.cell}\n::: {.cell-output-display}\n`````{=html}\n<table class=\"table table-striped table-hover\" style=\"margin-left: auto; margin-right: auto;\">\n<caption>Mortality association by pathogen class</caption>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\"> Pathogen Class </th>\n   <th style=\"text-align:left;\"> Studies (k) </th>\n   <th style=\"text-align:left;\"> Pooled OR </th>\n   <th style=\"text-align:left;\"> 95% CrI </th>\n   <th style=\"text-align:left;\"> P(OR &gt; 1) </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> Gram-Positive </td>\n   <td style=\"text-align:left;\"> 12 </td>\n   <td style=\"text-align:left;\"> 2.17 </td>\n   <td style=\"text-align:left;\"> 1.52 - 3.36 </td>\n   <td style=\"text-align:left;\"> 100% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> Gram-Negative </td>\n   <td style=\"text-align:left;\"> 14 </td>\n   <td style=\"text-align:left;\"> 2.06 </td>\n   <td style=\"text-align:left;\"> 1.48 - 3.15 </td>\n   <td style=\"text-align:left;\"> 100% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> Difference </td>\n   <td style=\"text-align:left;\"> — </td>\n   <td style=\"text-align:left;\"> 0.05 log-OR </td>\n   <td style=\"text-align:left;\"> -0.50 to 0.60 </td>\n   <td style=\"text-align:left;\"> 57.7% </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n::: {.callout-tip}\n## Clinical Implication\n\nThe TTP-mortality association is **similar across Gram-positive and Gram-negative infections** (no significant difference, P = 57.7%). This suggests TTP is a **pathogen-agnostic prognostic marker** that can be used immediately upon culture positivity, before organism identification is complete.\n:::\n\n## Next Steps\n\n- Review [Forest Plots](forest_plots.qmd) for visual representation of study-level results\n- Explore [Meta-Regression](meta_regression.qmd) analyses of moderating factors\n- Examine [Risk of Bias](risk_of_bias.qmd) assessment\n- Review [Publication Bias](publication_bias.qmd) sensitivity analyses\n",
    "supporting": [],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {
      "include-in-header": [
        "<script src=\"site_libs/kePrint-0.0.1/kePrint.js\"></script>\n<link href=\"site_libs/lightable-0.0.1/lightable.css\" rel=\"stylesheet\" />\n"
      ]
    },
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}